These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 35891331)

  • 1. Coronaviral Infection and Interferon Response: The Virus-Host Arms Race and COVID-19.
    Liu Q; Chi S; Dmytruk K; Dmytruk O; Tan S
    Viruses; 2022 Jun; 14(7):. PubMed ID: 35891331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options.
    Znaidia M; Demeret C; van der Werf S; Komarova AV
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways.
    Oh SJ; Shin OS
    J Microbiol; 2022 Mar; 60(3):290-299. PubMed ID: 35122601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the modulation of the interferon response and NAD
    Habeichi NJ; Tannous C; Yabluchanskiy A; Altara R; Mericskay M; Booz GW; Zouein FA
    Int Rev Immunol; 2022; 41(4):464-474. PubMed ID: 34378474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Update on Innate Immune Responses during SARS-CoV-2 Infection.
    Zhang Y; Chen S; Jin Y; Ji W; Zhang W; Duan G
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells.
    Metz-Zumaran C; Kee C; Doldan P; Guo C; Stanifer ML; Boulant S
    J Virol; 2022 Apr; 96(7):e0170521. PubMed ID: 35262371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy.
    Wang Y; Wu M; Li Y; Yuen HH; He ML
    J Biomed Sci; 2022 May; 29(1):27. PubMed ID: 35505345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies.
    Zhang S; Wang L; Cheng G
    Mol Ther; 2022 May; 30(5):1869-1884. PubMed ID: 35176485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When RING finger family proteins meet SARS-CoV-2.
    Cai C; Tang YD; Zheng C
    J Med Virol; 2022 Jul; 94(7):2977-2985. PubMed ID: 35257387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon antagonists encoded by SARS-CoV-2 at a glance.
    Lee JH; Koepke L; Kirchhoff F; Sparrer KMJ
    Med Microbiol Immunol; 2023 Apr; 212(2):125-131. PubMed ID: 35366686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host cell-intrinsic innate immune recognition of SARS-CoV-2.
    Madden EA; Diamond MS
    Curr Opin Virol; 2022 Feb; 52():30-38. PubMed ID: 34814102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion.
    Low ZY; Zabidi NZ; Yip AJW; Puniyamurti A; Chow VTK; Lal SK
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I IFNs: A Blessing in Disguise or Partner in Crime in MERS-CoV-, SARS-CoV-, and SARS-CoV-2-Induced Pathology and Potential Use of Type I IFNs in Synergism with IFN-
    Anjum FR; Anam S; Abbas G; Mahmood MS; Rahman SU; Goraya MU; Abdullah RM; Luqman M; Ali A; Akram MK; Chaudhry TH
    Viral Immunol; 2021 Jun; 34(5):321-329. PubMed ID: 33181057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Game of Infection - Song of Respiratory Viruses and Interferons.
    Wang GQ; Gu Y; Wang C; Wang F; Hsu AC
    Front Cell Infect Microbiol; 2022; 12():937460. PubMed ID: 35846766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Evaluation of Type 1 Interferon Related Genes in Male and Female-Matched, SARS-CoV-2 Infected Individuals Early in the COVID-19 Pandemic.
    Huecksteadt TP; Myers EJ; Aamodt SE; Trivedi S; Warren KJ
    Viruses; 2024 Mar; 16(3):. PubMed ID: 38543837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: Implications for treatment with IFN-β and IFN inducer.
    Shuai H; Chu H; Hou Y; Yang D; Wang Y; Hu B; Huang X; Zhang X; Chai Y; Cai JP; Chan JF; Yuen KY
    J Infect; 2020 Oct; 81(4):e1-e10. PubMed ID: 32707230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.
    Boechat JL; Chora I; Morais A; Delgado L
    Pulmonology; 2021; 27(5):423-437. PubMed ID: 33867315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired innate antiviral defenses in COVID-19: Causes, consequences and therapeutic opportunities.
    Galani IE; Andreakos E
    Semin Immunol; 2021 Jun; 55():101522. PubMed ID: 34815163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.